Eyelid Surgery Market Size To Reach $10.15 Billion By 2030

Eyelid Surgery Market Growth & Trends

The global eyelid surgery market size is anticipated to reach USD 10.15 billion by 2030 and is projected to expand at a CAGR of 5.6% during the forecast period, according to a new report by Grand View Research, Inc. The rising eye-related problems influenced by the growing geriatric population is one of the major factors contributing to the market growth. According to the International Society of Aesthetic Plastic Surgery (ISAPS), over 1.7 million eyelid surgeries were performed globally in 2023, marking a substantial 24% increase compared to the preceding year. This demographic trend underscores the rising need for surgical interventions to address age-related conditions such as ptosis and baggy eyelids.

The escalating preference for minimally invasive procedures is a key factor propelling market expansion. The advantages associated with these techniques, including faster recovery periods, enhanced patient comfort, and shorter turnaround times, are anticipated to fuel demand for advanced eyelid surgery techniques throughout the forecast period. Technological advancements in the field, exemplified by the development of innovative methods like Rinsada’s eyelid retractor, have further augmented the procedure's appeal by reducing associated risks and improving outcomes.

Recent activities among prominent companies in the market are also contributing to industry growth. Notably, in July 2024, Osheru, a medical device company specializing in innovative skin surgery solutions, announced the successful completion of a funding round that garnered over USD 4.0 million. This investment intended to accelerate the development and commercialization of Ziplyft, a medical device specifically designed to address challenges associated with blepharoplasty, indicating ongoing innovation and investment within the industry.

 Request a free sample copy or view report summary: Eyelid Surgery Market Report

Eyelid Surgery Market Report Highlights

• North America is the most dominant among all regions, with more than 37.0% of the total market share, driven by factors such as increase in geriatric population and minimally invasive technology

• Upper eyelid surgery dominated the procedure segment with more than 55.0% share in 2024 owing to its prominent application in curing and beautifying eyes

• The clinics and spa centers segment held the largest market share of over 65.0% in 2024 due to the increase in medical tourism and the geographical proliferation of advanced technology

• Increasing adoption of advanced medical tools and techniques is anticipated to boost market demand

Eyelid Surgery Market Segmentation

For the purpose of this report, Grand View Research has segmented the global eyelid surgery market on the basis of procedure, end-use, and region:

Eyelid Surgery Procedure Outlook (Revenue, USD Million, 2018 - 2030)

• Upper Eyelid Surgery

• Lower Eyelid Surgery

Eyelid Surgery End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Clinics and Spa Centers

Eyelid Surgery Region Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Thailand

  • South Korea

  • Australia

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Eyelid Surgery Market

• Integra LifeSciences Corporation

• Stanford Health Care

• Surgical Holdings

• Stryker

• American Society of Plastic Surgeons

• London Bridge Plastic Surgery

• Montenegro Clinic of Plastic Surgery

• Shoyukai Medical Association